Beihai Gofar Marine Biological Industry Co Ltd (600538) - Net Assets
Based on the latest financial reports, Beihai Gofar Marine Biological Industry Co Ltd (600538) has net assets worth CN¥785.32 Million CNY (≈ $114.92 Million USD) as of September 2025. Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets (CN¥964.41 Million ≈ $141.12 Million USD) and total liabilities (CN¥179.09 Million ≈ $26.21 Million USD). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off. Check Beihai Gofar Marine Biological Industry liquidity resilience to evaluate the company's liquid asset resilience ratio.
Key Net Assets Metrics
| Metric | Value |
|---|---|
| Current Net Assets | CN¥785.32 Million |
| % of Total Assets | 81.43% |
| Annual Growth Rate | 8.64% |
| 5-Year Change | -7.54% |
| 10-Year Change | 6.72% |
| Growth Volatility | 117.36 |
Beihai Gofar Marine Biological Industry Co Ltd - Net Assets Trend (1999–2024)
This chart illustrates how Beihai Gofar Marine Biological Industry Co Ltd's net assets have evolved over time, based on quarterly financial data. Also explore 600538 total assets for the complete picture of this company's asset base.
Annual Net Assets for Beihai Gofar Marine Biological Industry Co Ltd (1999–2024)
The table below shows the annual net assets of Beihai Gofar Marine Biological Industry Co Ltd from 1999 to 2024. For live valuation and market cap data, see market value of Beihai Gofar Marine Biological Industry .
| Year | Net Assets | Change |
|---|---|---|
| 2024-12-31 | CN¥787.39 Million ≈ $115.22 Million |
-10.45% |
| 2023-12-31 | CN¥879.30 Million ≈ $128.67 Million |
-8.40% |
| 2022-12-31 | CN¥959.98 Million ≈ $140.48 Million |
+4.05% |
| 2021-12-31 | CN¥922.61 Million ≈ $135.01 Million |
+8.34% |
| 2020-12-31 | CN¥851.56 Million ≈ $124.61 Million |
+31.90% |
| 2019-12-31 | CN¥645.61 Million ≈ $94.47 Million |
+1.26% |
| 2018-12-31 | CN¥637.56 Million ≈ $93.30 Million |
-3.28% |
| 2017-12-31 | CN¥659.18 Million ≈ $96.46 Million |
-4.30% |
| 2016-12-31 | CN¥688.79 Million ≈ $100.79 Million |
-6.65% |
| 2015-12-31 | CN¥737.84 Million ≈ $107.97 Million |
+1.13% |
| 2014-12-31 | CN¥729.59 Million ≈ $106.76 Million |
+554.16% |
| 2013-12-31 | CN¥111.53 Million ≈ $16.32 Million |
+21.76% |
| 2012-12-31 | CN¥91.60 Million ≈ $13.40 Million |
-52.20% |
| 2011-12-31 | CN¥191.61 Million ≈ $28.04 Million |
-15.02% |
| 2010-12-31 | CN¥225.47 Million ≈ $32.99 Million |
+8.73% |
| 2009-12-31 | CN¥207.37 Million ≈ $30.34 Million |
-36.28% |
| 2008-12-31 | CN¥325.43 Million ≈ $47.62 Million |
-33.98% |
| 2007-12-31 | CN¥492.89 Million ≈ $72.13 Million |
-6.89% |
| 2006-12-31 | CN¥529.39 Million ≈ $77.47 Million |
-3.98% |
| 2005-12-31 | CN¥551.30 Million ≈ $80.67 Million |
+5.59% |
| 2004-12-31 | CN¥522.14 Million ≈ $76.41 Million |
+9.04% |
| 2003-12-31 | CN¥478.86 Million ≈ $70.07 Million |
+224.58% |
| 2002-12-31 | CN¥147.53 Million ≈ $21.59 Million |
+13.36% |
| 2001-12-31 | CN¥130.15 Million ≈ $19.05 Million |
+23.39% |
| 2000-12-31 | CN¥105.48 Million ≈ $15.44 Million |
+6.42% |
| 1999-12-31 | CN¥99.12 Million ≈ $14.50 Million |
-- |
Equity Component Analysis
This analysis shows how different components contribute to Beihai Gofar Marine Biological Industry Co Ltd's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.
Equity Composition Insights
- Retained earnings have decreased by 2617.1% over the analyzed period, potentially due to dividend distributions or operating losses.
Current Equity Component Breakdown (December 2024)
| Component | Amount | Percentage |
|---|---|---|
| Common Stock | CN¥524.20 Million | 67.60% |
| Other Components | CN¥817.78 Million | 105.47% |
| Total Equity | CN¥775.39 Million | 100.00% |
Beihai Gofar Marine Biological Industry Co Ltd Competitors by Market Cap
The table below lists competitors of Beihai Gofar Marine Biological Industry Co Ltd ranked by their market capitalization.
| Company | Market Cap |
|---|---|
|
Clenergy Xiamen Technology Co Ltd
SHG:603628
|
$498.75 Million |
|
Issta Lines Ltd
TA:ISTA
|
$498.88 Million |
|
Shelf Drilling Ltd
OL:SHLF
|
$498.91 Million |
|
Anglo American PLC
LSE:AAL
|
$498.99 Million |
|
Nanjing TDH Technology Co. Ltd. A
SHE:301378
|
$498.56 Million |
|
SunOpta Inc.
NASDAQ:STKL
|
$498.43 Million |
|
Ichitan Group Public Company Limited
BK:ICHI-R
|
$498.39 Million |
|
Kaiser China Holding Co Ltd
SHE:002425
|
$498.37 Million |
Equity Growth Attribution
This analysis shows how different factors contributed to changes in Beihai Gofar Marine Biological Industry Co Ltd's equity between the two most recent reporting periods.
Equity Growth Insights
- From 2023 to 2024, total equity changed from 869,237,165 to 775,386,925, a change of -93,850,240 (-10.8%).
- Net loss of 93,850,240 reduced equity.
- Other comprehensive income decreased equity by 48,907,873.
- Other factors increased equity by 48,907,873.
Equity Change Factors (2023 to 2024)
| Factor | Impact | Contribution |
|---|---|---|
| Net Income | CN¥-93.85 Million | -12.1% |
| Other Comprehensive Income | CN¥-48.91 Million | -6.31% |
| Other Changes | CN¥48.91 Million | +6.31% |
| Total Change | CN¥- | -10.80% |
Book Value vs Market Value Analysis
This analysis compares Beihai Gofar Marine Biological Industry Co Ltd's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.
Valuation Insights
- Current price-to-book ratio: 4.39x
- The company is trading at a significant premium to its book value, suggesting the market values its earnings potential, brand, or other intangibles highly.
- The price-to-book ratio has decreased from 17.82x to 4.39x over the analyzed period, indicating reduced market premium.
Historical Price-to-Book Ratios
| Date | Book Value per Share | Market Price | P/B Ratio |
|---|---|---|---|
| 1999-12-31 | CN¥0.36 | CN¥6.50 | x |
| 2000-12-31 | CN¥0.39 | CN¥6.50 | x |
| 2001-12-31 | CN¥0.48 | CN¥6.50 | x |
| 2002-12-31 | CN¥0.71 | CN¥6.50 | x |
| 2003-12-31 | CN¥2.29 | CN¥6.50 | x |
| 2004-12-31 | CN¥2.41 | CN¥6.50 | x |
| 2005-12-31 | CN¥2.50 | CN¥6.50 | x |
| 2006-12-31 | CN¥1.73 | CN¥6.50 | x |
| 2007-12-31 | CN¥1.84 | CN¥6.50 | x |
| 2008-12-31 | CN¥1.10 | CN¥6.50 | x |
| 2009-12-31 | CN¥0.58 | CN¥6.50 | x |
| 2010-12-31 | CN¥0.65 | CN¥6.50 | x |
| 2011-12-31 | CN¥0.49 | CN¥6.50 | x |
| 2012-12-31 | CN¥0.10 | CN¥6.50 | x |
| 2013-12-31 | CN¥0.17 | CN¥6.50 | x |
| 2014-12-31 | CN¥1.79 | CN¥6.50 | x |
| 2015-12-31 | CN¥1.68 | CN¥6.50 | x |
| 2016-12-31 | CN¥1.43 | CN¥6.50 | x |
| 2017-12-31 | CN¥1.49 | CN¥6.50 | x |
| 2018-12-31 | CN¥1.48 | CN¥6.50 | x |
| 2019-12-31 | CN¥1.39 | CN¥6.50 | x |
| 2020-12-31 | CN¥1.65 | CN¥6.50 | x |
| 2021-12-31 | CN¥1.75 | CN¥6.50 | x |
| 2022-12-31 | CN¥1.82 | CN¥6.50 | x |
| 2023-12-31 | CN¥1.69 | CN¥6.50 | x |
| 2024-12-31 | CN¥1.48 | CN¥6.50 | x |
Capital Efficiency Dashboard
This dashboard shows how efficiently Beihai Gofar Marine Biological Industry Co Ltd utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.
Capital Efficiency Insights
- Current Return on Equity (ROE): -12.10%
- The company may be facing challenges in efficiently utilizing shareholder equity.
- DuPont Analysis Breakdown:
- • Net Profit Margin: -27.57%
- • Asset Turnover: 0.35x
- • Equity Multiplier: 1.25x
- Recent ROE (-12.10%) is above the historical average (-18.60%), indicating improving capital efficiency.
Historical Capital Efficiency Metrics
| Year | Return on Equity | Net Profit Margin | Asset Turnover | Equity Multiplier | Economic Value Added |
|---|---|---|---|---|---|
| 1999 | 16.37% | 25.27% | 0.38x | 1.68x | CN¥6.31 Million |
| 2000 | 14.89% | 19.16% | 0.42x | 1.87x | CN¥5.13 Million |
| 2001 | 19.00% | 26.15% | 0.46x | 1.60x | CN¥11.65 Million |
| 2002 | 16.68% | 23.93% | 0.42x | 1.66x | CN¥9.49 Million |
| 2003 | 6.15% | 12.15% | 0.31x | 1.62x | CN¥-17.62 Million |
| 2004 | 3.37% | 4.34% | 0.36x | 2.17x | CN¥-31.87 Million |
| 2005 | 3.56% | 3.84% | 0.36x | 2.54x | CN¥-32.11 Million |
| 2006 | -6.43% | -5.60% | 0.41x | 2.77x | CN¥-77.22 Million |
| 2007 | 0.64% | 0.38% | 0.60x | 2.75x | CN¥-44.51 Million |
| 2008 | -57.65% | -54.21% | 0.27x | 3.94x | CN¥-207.36 Million |
| 2009 | -86.63% | -57.36% | 0.26x | 5.90x | CN¥-154.41 Million |
| 2010 | 9.28% | 4.52% | 0.51x | 4.00x | CN¥-1.27 Million |
| 2011 | -28.35% | -7.38% | 0.76x | 5.06x | CN¥-52.81 Million |
| 2012 | -389.29% | -20.18% | 0.88x | 21.81x | CN¥-112.38 Million |
| 2013 | 24.03% | 2.36% | 0.65x | 15.53x | CN¥6.24 Million |
| 2014 | -7.25% | -11.84% | 0.42x | 1.46x | CN¥-117.01 Million |
| 2015 | 0.59% | 0.80% | 0.51x | 1.44x | CN¥-64.17 Million |
| 2016 | -4.90% | -7.00% | 0.48x | 1.47x | CN¥-96.89 Million |
| 2017 | 1.34% | 2.04% | 0.56x | 1.18x | CN¥-57.07 Million |
| 2018 | -3.39% | -9.63% | 0.29x | 1.20x | CN¥-85.37 Million |
| 2019 | 0.89% | 2.30% | 0.33x | 1.16x | CN¥-58.79 Million |
| 2020 | 0.38% | 1.20% | 0.25x | 1.26x | CN¥-81.24 Million |
| 2021 | 1.14% | 2.47% | 0.39x | 1.18x | CN¥-81.18 Million |
| 2022 | 3.66% | 7.58% | 0.40x | 1.20x | CN¥-60.31 Million |
| 2023 | -9.47% | -22.30% | 0.35x | 1.21x | CN¥-169.23 Million |
| 2024 | -12.10% | -27.57% | 0.35x | 1.25x | CN¥-171.39 Million |
Industry Comparison
This section compares Beihai Gofar Marine Biological Industry Co Ltd's net assets metrics with peer companies in the Agricultural Inputs industry.
Industry Context
- Industry: Agricultural Inputs
- Average net assets among peers: $2,123,924,630
- Average return on equity (ROE) among peers: 11.07%
Peer Company Comparison
| Company | Net Assets | Return on Equity | Debt-to-Equity | Market Cap |
|---|---|---|---|---|
| Beihai Gofar Marine Biological Industry Co Ltd (600538) | CN¥785.32 Million | 16.37% | 0.23x | $498.59 Million |
| Hubei Yihua Chemical Industry Co Ltd (000422) | $7.06 Billion | 11.58% | 2.79x | $2.67 Billion |
| Nanjing Red Sun Co Ltd (000525) | $5.53 Billion | 12.91% | 1.22x | $1.03 Billion |
| ADAMA Ltd (000553) | $2.01 Billion | 45.23% | 0.46x | $2.39 Billion |
| Grand Industrial Holding Co Ltd (000626) | $2.66 Billion | -7.24% | 2.38x | $682.05 Million |
| Sichuan Meifeng Chemical Industry Co Ltd (000731) | $790.66 Million | 10.11% | 0.66x | $572.61 Million |
| Qinghai Salt Lake Industry Co.Ltd (000792) | $138.79 Million | 24.98% | 1.61x | $31.28 Billion |
| Asia Potash International Investment Guangzhou Co Ltd (000893) | $413.91 Million | 8.29% | 1.31x | $7.51 Billion |
| Hubei Xinyangfeng Fertilizer Co Ltd (000902) | $452.01 Million | -10.57% | 1.67x | $2.83 Billion |
| Sichuan Lutianhua Co Ltd (000912) | $1.83 Billion | 8.54% | 0.96x | $1.09 Billion |
| Guangxi Hechi Chemical Co Ltd (000953) | $362.48 Million | 6.90% | 1.25x | $372.35 Million |
About Beihai Gofar Marine Biological Industry Co Ltd
Beihai Gofar Chuanshan Biological Co., Ltd., together with its subsidiaries, engages in the distribution of pharmaceutical products in China. It operates through Pharmaceutical Distribution [Industry]; Pharmaceutical Manufacturing; DNA Testing Equipment, Consumables and Testing Services; and Others segments. The company wholesales and retails various medicines and medical devices through directly… Read more